Skip to main content

Table 3 Mean length of stay for type of exacerbation management and distribution of individuals undergoing each management type

From: Analysis of length of stay and treatment emergent complications in hospitalized myasthenia gravis patients with exacerbation

Exacerbation Management Per Event

(n = 141)

Mean Length of Stay in Days (SD)

Number of Unique Individuals

(n = 70)

IVIG

6.38 (7.0)

43

No IVIG

10.69 (12.0)

27

Plasmapheresis

13.2 (12.8)

39

No Plasmapheresis

4.63 (4.1)

31

IVIG and Plasmapheresis

17.9 (10.52)

10

No IVIG or Plasmapheresis

4.14 (4.0)

13

Intubation

21.64 (17.0)

21

No Intubation

5.77 (4.3)

49

ICU

16.43 (5.4)

7

Non-ICU

8.17 (10.12)

63

Total

8.58 (10.1)

70